Cellicon Valley '23:
The Future of Cell and Gene Therapies Educational Symposium
Overview
June 21-23, 2023
In Person at
Irvine Auditorium
3401 Spruce Street
Philadelphia, PA 19104
or
Virtually via AJI Media Livecast
Learning Objectives
Upon completion of this symposium, participants should be able to:
- Identify current application of CAR T-cell therapy including: disease indication, accurate patient selection, manufacturing and treatment administration for adult and pediatric patients
- Describe the latest for CAR T-Cell Therapy for T Cell ALL, multiple myeloma and CLL
- List challenges and opportunities for equitable patient access
- Explain the risk of malignancies and curative therapies for hemoglobinopathies
- Identify the current status of globalization of cell and gene therapies
- Describe the latest targets and technologies for CARs
- Define toxicity and its management
- Identify mechanisms of resistance and how to overcome it
- List recent advances in cell therapy for solid tumors
- Describe chimeric antigen receptor T Cells for T Cell malignancies
- Identify the latest evidence based standards in nursing care resulting from the recent advances in cell therapy and transplant:
- Identify advances in re-treatment
- List the latest updates in fertility preservation
- Describe the challenges with navigating and coordination of BMT/cell gene therapies and CAR-T
- Explain how bispecific antibodies work
- List standards of care and practice related to cell therapy infusion day
- Repeat the rationale for nursing to remain current with new and upcoming therapies
Published
April 4, 2023
Created by
BROADCASTMED